An Association Study of Polymorphisms in JAK3 Gene with Lung Cancer in the Korean Population
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose The genetic alteration of the janus kinases (JAKs), non-receptor tyrosine kinase, is related to the development of human cancers. However, little is known about how the sequence variation of JAK3 contributes to the development of lung cancer. This study investigated whether polymorphisms at the promoter region of the JAK3 gene are associated with the risk of lung cancer in the Korean population. Materials and Methods A total of 819 subjects, including 409 lung cancer patients and 410 healthy controls were recruited. The SNaPshot assay and polymerase chain reaction-restriction fragment length polymorphism analysis were used, and logistic regression analyses were performed to characterize the association between polymorphisms of JAK3 and lung cancer risk. Results Three polymorphisms (-672 G＞A, +64 A＞G and +227 G＞A) of JAK3 were analyzed for large-scale genotyping (n=819). Statistical analyses revealed that polymorphisms and haplotypes in the JAK3 gene were not significantly associated with lung cancer. Conclusion JAK3 gene was not significantly associated with the risk of lung cancer in the Korean population.
Abstract
Purpose The genetic alteration of the janus kinases (JAKs), non-receptor tyrosine kinase, is related to the development of human cancers. However, little is known about how the sequence variation of JAK3 contributes to the development of lung cancer. This study investigated whether polymorphisms at the promoter region of the JAK3 gene are associated with the risk of lung cancer in the Korean population. Materials and Methods A total of 819 subjects, including 409 lung cancer patients and 410 healthy controls were recruited. The SNaPshot assay and polymerase chain reaction-restriction fragment length polymorphism analysis were used, and logistic regression analyses were performed to characterize the association between polymorphisms of JAK3 and lung cancer risk. Results Three polymorphisms (-672 G＞A, +64 A＞G and +227 G＞A) of JAK3 were analyzed for large-scale genotyping (n=819). Statistical analyses revealed that polymorphisms and haplotypes in the JAK3 gene were not significantly associated with lung cancer. Conclusion JAK3 gene was not significantly associated with the risk of lung cancer in the Korean population.
참고문헌 (25)
- Parkin DM, "Cancer burden in the year 2000: the global picture", Eur J Cancer, 37(8), pp.S4~S66 (2001)
- Jemal A, "Cancer statistics, 2006", CA Cancer J Clin, 56, pp.106~130 (2006)
- Hai-Rim Shin, "Nationwide Cancer Incidence in Korea, 1999~2001; First Result Using the National Cancer Incidence Database", Cancer Research and Treatment, 37(6), pp.325~331 (2005), 대한암학회
- Fong KM, "Lung cancer. 9. Molecular biology of lung cancer: clinical implications", Thorax, 58, pp.892~900 (2003)
- Bache KG, "Defective downregulation of receptor tyrosine kinases in cancer", EMBO J, 23, pp.2707~2712 (2004)
- Blume-Jensen P, "Oncogenic kinase signalling", Nature, 411, pp.355~365 (2001)
- Zhu J, "Stat5 activation plays a critical role in Th2 differentiation", Immunity, 19, pp.739~748 (2003)
- Buettner R, "Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention", Clin Cancer Res, 8, pp.945~954 (2002)
- Bromberg J, "Stat proteins and oncogenesis", J Clin Invest, 109, pp.1139~1142 (2002)
- Yu H, "The STATs of cancer: new molecular targets come of age", Nat Rev Cancer, 4, pp.97~105 (2004)
- Walters DK, "Activating alleles of JAK3 in acute megakaryoblastic leukemia", Cancer Cell, 10, pp.65~75 (2006)
- Jeong EG, "Somatic mutations of JAK1 and JAK3 in acute leukemias and solid cancers", CLINICAL CANCER RESEARCH, 14, pp.3716~3721 (2008), AMER ASSOC CANCER RESEARCH
- Mori D, "Differential expression of Janus kinase 3 (JAK3), matrix metalloproteinase 13 (MMP13), heat shock protein 60 (HSP60), and mouse double minute 2 (MDM2) in human colorectal cancer progression using human cancer cDNA microarrays", Pathol Res Pract, 201, pp.777~789 (2005)
- Lin Q, "Constitutive activation of JAK3", STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3, Am J Pathol, pp.2005, 167[DOI]
- Jo UH, "The genetic polymorphisms of HER-2 and the risk of lung cancer in a Korean population", BMC CANCER, 9, pp.359~ (2008), BIOMED CENTRAL LTD
- Li WX, "Canonical and non-canonical JAK-STAT signaling", Trends Cell Biol, 18, pp.545~551 (2008)
- Alam R, "The interleukin-5", receptor interaction activates Lyn and Jak2 tyrosine kinases and propagates signals via the Ras-Raf-1- MAP kinase and the Jak-STAT pathways in eosinophils, 1995, pp.107, 226~227
- Kumar G, "Involvement of Janus kinases, p52shc, Raf-1, and MEK-1 in the IL-6-induced mitogen-activated protein kinase cascade of a growthresponsive B cell line", J Immunol, 153, pp.4436~4447 (1994)
- Krejsgaard T, "Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma", Leukemia, 20, pp.1759~1766 (2006)
- Rocha-Zavaleta L, "Interleukin-2 (IL-2) receptor-betagamma signalling is activated by c-Kit in the absence of IL-2, or by exogenous IL-2 via JAK3", STAT5 in human papillomavirus- associated cervical cancer, 2004, pp.16, 1239~1247
- Liu J, "Neuregulin-1 activates the JAK-STAT pathway and regulates lung epithelial cell proliferation", Am J Respir Cell Mol Biol, 27, pp.306~313 (2002)
- Cassidy A, "Lung cancer risk prediction: a tool for early detection", Int J Cancer, 120, pp.1~6 (2007)
- Lam WK, "Lung cancer in Asian women-the environment and genes", Respirology, 10, pp.408~417 (2005)
- Suzuki T, "Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case control study", Carcinogenesis, 28, pp.1718~1725 (2007)
- Shields PG, "Cancer risk and low-penetrance susceptibility genes in geneenvironment interactions", J Clin Oncol, 18, pp.2309~2315 (2000)